Hypercoagulability in Vestibular Schwannoma Surgery
- PMID: 33065597
- DOI: 10.1097/MAO.0000000000002934
Hypercoagulability in Vestibular Schwannoma Surgery
Abstract
Objective: Patients with vestibular schwannoma who harbor a genetic predisposition for venous thromboembolism require special consideration when determining optimal therapeutic management. The primary objective of the current study was to provide recommendations on treatment of hypercoagulable patients with vestibular schwannoma through a case series and review of the literature.
Patients: Two patients who underwent resection of vestibular schwannomas.
Interventions: Surgical resection and diagnostic testing.
Main outcome measures: Postoperative venous thromboses.
Results: One patient who underwent resection of vestibular schwannoma and suffered several postoperative thrombotic complications consistent with a clinical thrombophilia. One patient with known Factor V Leiden deficiency who underwent resection of vestibular schwannoma followed by postoperative chemoprophylaxis with a direct factor Xa inhibitor and experienced an uneventful postoperative course.
Conclusions: In patients with a known propensity for venous thromboembolism, the skull base surgeon should consider nonsurgical management. If the patient undergoes surgical resection, we recommend careful effort to minimize trauma to the sigmoid sinus. In addition, the surgeon may consider retrosigmoid or middle fossa approaches. Best practice recommendations include the use of pneumatic compression devices, early ambulation, and consideration of postoperative prophylactic anticoagulation in patients with a known genetic predisposition.
Copyright © 2020, Otology & Neurotology, Inc.
Conflict of interest statement
The authors disclose no conflicts of interest.
References
-
- Kumar D, Hanlin E, Glurich I, Mazza J, Yale S. Virchow's contribution to the understanding of thrombosis and cellular biology. Clin Med Res 2010; 8:168–172.
-
- Lee KS, TerBrugge KG. Cerebral venous thrombosis in adults: The role of imaging evaluation and management. Neuroimaging Clin N Am 2003; 13:139–152.
-
- Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ. Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Arch Intern Med 2000; 160:809–815.
-
- Steven A, Raghavan P, Altmeyer W, Gandhi D. Venous thrombosis. Hematol Oncol Clin North Am 2016; 30:867–885.
-
- Zuurbier SM, Coutinho JM. Cerebral venous thrombosis. Adv Exp Med Biol 2017; 906:183–193.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical